Echoiq Limited has released a press release.
US Based CEO Appointed to Execute Commercialisation Strategy
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from EchoIQ
- Major Milestone Achieved with FDA Clearance for EchoSolv AS
- Echo IQ Raises $7.1 million
- Groundbreaking study results for Heart Failure AI solution
- Strategic Integration Partnership Agreement with ScImage Inc
- Validation of EIQ AI at Leading Scientific Conference
Later from EchoIQ
- EIQ signs integration agreement with Flagship US Hospital
- S&P DJI Announces December 2024 Quarterly Rebalance
- The First Step in EIQs US Market Commercialisation Strategy
- Pre-submission meeting with US FDA for heart failure
- Response to ASX Query Letter
Follow EchoIQ into a list and get an email when it puts out news.
Follow EchoIQ